Toxic Gas Detector Family Receives ATEX Approval

Safety

Toxic Gas Detector Family Receives ATEX Approval

19 Jul, 2010

Published over 16 years ago. See the latest and most current information on Safety.

US manufacturer Detector Electronics Corporation (Det-Tronics) GT3000 Toxic Gas Detectors have received ATEX hazardous location and performance certification. In addition, GT3000 Toxic Gas Detectors are FM, CSA, CE, and IECEx certified and have earned the IP66 rating. Det-Tronics is part of UTC Fire & Security, a unit of United Technologies Corp.

The GT3000 family is a group of electrochemical fixed-point detectors that provide non-intrusive calibration, communication via 4-20mA with HART protocol, and the ability to swap sensors without de-classifying hazardous areas. A GT3000 detector consists of a transmitter (GTX) and a sensor module (GTS). The transmitter generates a 4-20mA output signal with HART that is proportional to the concentration of the target gas and corresponds directly to 0-100% full scale.

Currently, the GT3000 family includes sensors that detect these gases: hydrogen sulphide (H2S), oxygen (O2), carbon monoxide (CO), ammonia (NH3), chlorine (Cl2), and sulfur dioxide (SO2). More gases will be added soon.

“Although GT3000 is approved as a stand-alone device,” says product development manager Mike Bragg, “many users choose to partner it with Det-Tronics’ FlexVu® Universal Display for quick device set up and easy access to sensor status.”

Latest News

PIN 27.3 June/July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Review suggests eating less protein could extend healthy lifespan in inactive adults
Explore more Arrow
Envirotech Online
Reflected light from everyday surfaces enables remote detection of hazardous aerosols
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow